Drug
Bms 986299
Bms 986299: highest development phase Phase 1, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMS-986299 NCT03444753 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow Bms 986299 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.